{
    "organizations": [],
    "uuid": "b9e80f0a9d632509166202b448556b6b99abd007",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-keryx-biopharmaceuticals-reports-q/brief-keryx-biopharmaceuticals-reports-q1-loss-per-share-of-0-18-idUSASC0A1D6",
    "ord_in_thread": 0,
    "title": "BRIEF-Keryx Biopharmaceuticals Reports Q1 Loss Per Share Of $0.18",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Keryx Biopharmaceuticals Inc:\n* KERYX BIOPHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.18 * Q1 REVENUE $21.7 MILLION VERSUS I/B/E/S VIEW $21.8 MILLION\n* Q1 EARNINGS PER SHARE VIEW $-0.18 â€” THOMSON REUTERS I/B/E/S\n* CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2018 TOTALED $60.1 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T19:13:00.000+03:00",
    "crawled": "2018-05-11T13:01:08.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "keryx",
        "biopharmaceuticals",
        "inc",
        "keryx",
        "biopharmaceuticals",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "cash",
        "cash",
        "equivalent",
        "march",
        "totaled",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}